A 52-year-old man with newly diagnosed acute myeloid leukaemia (AML) is started on cytarabine as part of induction chemotherapy. On day 5 of treatment, he develops severe mucositis and diarrhoea. Which investigation would be most appropriate to assess for cytarabine-induced cerebellar syndrome, a dose-limiting toxicity?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.